Next, to assess the CTGF level if it was characteristic with FALD, we examined 65 patients with another etiology of liver fibrosis, NAFLD whose liver fibrosis stage had been confirmed by biopsy. This evidence concerns the gene CCN2 and metabolic dysfunction-associated steatotic liver disease.